Creo Medical Group (LSE:CREO) Scaled Net Operating Assets : 0.68 (As of Jun. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Creo Medical Group Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Creo Medical Group's operating assets for the quarter that ended in Jun. 2024 was £59.50 Mil. Creo Medical Group's operating liabilities for the quarter that ended in Jun. 2024 was £7.70 Mil. Creo Medical Group's Total Assets for the quarter that ended in Dec. 2023 was £76.60 Mil. Therefore, Creo Medical Group's scaled net operating assets (SNOA) for the quarter that ended in Jun. 2024 was 0.68.

Creo Medical Group Scaled Net Operating Assets Historical Data

The historical data trend for Creo Medical Group's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Creo Medical Group Scaled Net Operating Assets Chart

Creo Medical Group Annual Data

Trend

Feb14

Feb15

Feb16

Jun17

Dec19

Dec20

Dec21

Dec22

Dec23

Scaled Net Operating Assets

Get a 7-Day Free Trial

0.15

0.34

0.44

0.48

0.66

Creo Medical Group Semi-Annual Data
	Feb14	Feb15	Feb16	Dec16	Jun17	Dec17	Jun18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Scaled Net Operating Assets	Get a 7-Day Free Trial													0.47	0.55	0.69	0.56	0.68

Competitive Comparison of Creo Medical Group's Scaled Net Operating Assets

For the Medical Devices subindustry, Creo Medical Group's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Creo Medical Group's Scaled Net Operating Assets Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Creo Medical Group's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Creo Medical Group's Scaled Net Operating Assets falls into.

Creo Medical Group Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Creo Medical Group's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Dec. 2023 )
=	(Operating Assets (A: Dec. 2023 )	-	Operating Liabilities (A: Dec. 2023 ))	/	Total Assets (A: Dec. 2022 )
=	(58.1	-	8.5)	/	75.2
=	0.66

where

	Operating Assets		(A: Dec. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	76.6	-	18.5
=	58.1

	Operating Liabilities		(A: Dec. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	16.8	-	5.2	-	3.1
=	8.5

Creo Medical Group's Scaled Net Operating Assets (SNOA) for the quarter that ended in Jun. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Jun. 2024 )
=	(Operating Assets (Q: Jun. 2024 )	-	Operating Liabilities (Q: Jun. 2024 ))	/	Total Assets (Q: Dec. 2023 )
=	(59.5	-	7.7)	/	76.6
=	0.68

where

	Operating Assets		(Q: Jun. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	69.3	-	9.8
=	59.5

	Operating Liabilities		(Q: Jun. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	21.9	-	10.7	-	3.5
=	7.7

Creo Medical Group Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Creo Medical Group's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Creo Medical Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Creo Medical Group PLC (LSE:CREO) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

Beaufort Park Way, Unit 2, Creo House, Beaufort Park, Chepstow, GBR, NP16 5UH

Website

https://www.creomedical.com

Creo Medical Group PLC is a medical device company engaged in providing services in the field of surgical endoscopy. The company has developed a platform called Croma which is an electrosurgical platform to deliver microwave and bipolar radiofrequency through a single accessory port. The reportable segment of the company is the research and development of electrosurgical medical devices relating to the field of surgical endoscopy. Geographically, the company generates a majority of its revenue from Europe and the rest from the United Kingdom and the rest of the world.

Creo Medical Group Headlines

No Headlines